Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 1
2023 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Entomophthoramycosis: An unusual cause of facial disfigurement.
Mondal A, Basu A, Mandal M, Mallik A, Modak DC, Pal D, Majumder D, Guha SK. Mondal A, et al. Among authors: modak dc. Drug Discov Ther. 2021;15(6):341-343. doi: 10.5582/ddt.2021.01095. Drug Discov Ther. 2021. PMID: 35034927 Free article.
Correction to: Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
Sinha S, Ajayababu A, Thukral H, Gupta S, Guha SK, Basu A, Gupta G, Thakur P, Lingaiah R, Das BK, Singh UB, Singh R, Narang R, Bhowmik D, Wig N, Modak DC, Bandyopadhyay B, Chakrabarty B, Kapoor A, Tewari S, Prasad N, Hashim Z, Nath A, Kumari N, Goswami R, Pandey S, Pandey RM. Sinha S, et al. Among authors: modak dc. Infect Dis Ther. 2023 Mar;12(3):1017-1018. doi: 10.1007/s40121-023-00770-9. Infect Dis Ther. 2023. PMID: 36795304 Free PMC article. No abstract available.
Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial.
Sinha S, Ajayababu A, Thukral H, Gupta S, Guha SK, Basu A, Gupta G, Thakur P, Lingaiah R, Das BK, Singh UB, Singh R, Narang R, Bhowmik D, Wig N, Modak DC, Bandyopadhyay B, Chakrabarty B, Kapoor A, Tewari S, Prasad N, Hashim Z, Nath A, Kumari N, Goswami R, Pandey S, Pandey RM. Sinha S, et al. Among authors: modak dc. Infect Dis Ther. 2022 Dec;11(6):2205-2217. doi: 10.1007/s40121-022-00703-y. Epub 2022 Oct 15. Infect Dis Ther. 2022. PMID: 36242739 Free PMC article.